HomeScientific literature watchCeftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial

[acf:scientific_post_journal] • [acf:scientific_post_date]

, , ,